Supportive Care Perspectives™ is the only resource providing in-depth analysis of supportive care conditions in the U.S. oncology market. The Supportive Care Perspectives™ report series leverages MattsonJack DaVinci’s in-depth expertise in the U.S. cancer marketplace to provide a comprehensive review and analysis of supportive care conditions. Focusing on this large and growing market segment, Supportive Care Perspectives™ provides robust, detailed profiles of 15 supportive care conditions related to cancer treatment, symptomatology, and disease progression.

Supportive Care Perspectives™ provides marketing, business development, and strategic planning personnel invaluable information on the current and future supportive care cancer market that:

• Provides a qualitative and quantitative assessment of the current and future supportive care market
• Increases your awareness of current thought-leader and community physician opinions
• Improves forecasting confidence via better data granularity and impact of future events
• Validates or challenges in-house assumptions by providing an independent assessment
• Includes access to MattsonJack DaVinci’s dedicated oncology researchers and consultants

Supportive Care Perspectives™
now includes European
epidemiology numbers!

Also, epidemiology numbers
for supportive care
in Japan are available
as an additional option.

Our Comprehensive Methodology Strengthens Your Judgment

MattsonJack DaVinci’s comprehensive approach ensures you have the most relevant, up-to-date, and validated data about the supportive care marketplace:

• Real-World Insights on Treatment Trends and Decisions from 2,400+ Physicians. Our primary market research surveys of practicing radiation oncologists, medical oncologists, hematologists, and urologists ascertain the frequency and treatment of each condition by stage and by cancer. These surveys represent the insights of 2,400+ physicians who treat 199,000+ patients monthly.
• Up-to-Date Analysis on the Newest Agents in Development. Our consultants attend the ASCO Annual Meeting, MASCC Supportive Care meeting, and other appropriate symposia. We thoroughly review relevant literature, clinical data presentations and new guidelines and conduct primary marketing research interviews with key industry personnel and opinion leaders.
• Validation of Data and Realistic Market Opportunities. We conduct a rigorous analysis of incidence based on physician-reported rates validated by published toxicities from major Phase III trials and utilize Active Disease data to project the base population of each supportive care condition.